Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes-Reference-Cited by-同舟云学术

Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes

Published:1999-08 Issue:8 Volume:39 Page:818-823
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Lazarus A.H.,Crow A.R,Freedman J.,Blanchette V.,Hannach B.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1537-2995.1999.39080818.x/fullpdf

Reference29 articles.

1. Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet Transfusions

2. Induction of a secondary human anti-HLA alloimmune response in severe combined immunodeficient mice engrafted with human lymphocytes

3. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.

4. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Options for Immunologic Support of Renal Transplantation Through the HLA and Immunology Laboratories;American Journal of Transplantation;2007-06

2. Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid;Clinical and Experimental Immunology;2004-06-15

3. SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions;Frontiers in Bioscience;2002

4. Human–SCID mouse chimeric models for the evaluation of anti-cancer therapies;Trends in Immunology;2001-07

5. Monoclonal antibody-mediated inhibition of the human HLA alloimmune response to platelet transfusion is antigen specific and independent of Fcγ receptor-mediated immune suppression;British Journal of Haematology;2000-08